The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often considered as outdated and hindering https://bookmarklinx.com/story20815862/marijuana-rescheduling-a-expansion-catalyst